Format

Send to

Choose Destination
Rejuvenation Res. 2015 Oct;18(5):422-36. doi: 10.1089/rej.2014.1656. Epub 2015 Sep 22.

Cryoprotectant Toxicity: Facts, Issues, and Questions.

Author information

1
Life Extension Foundation , Coconut Creek, Florida.

Abstract

High levels of penetrating cryoprotectants (CPAs) can eliminate ice formation during cryopreservation of cells, tissues, and organs to cryogenic temperatures. But CPAs become increasingly toxic as concentration increases. Many strategies have been attempted to overcome the problem of eliminating ice while minimizing toxicity, such as attempting to optimize cooling and warming rates, or attempting to optimize time of adding individual CPAs during cooling. Because strategies currently used are not adequate, CPA toxicity remains the greatest obstacle to cryopreservation. CPA toxicity stands in the way of cryogenic cryopreservation of human organs, a procedure that has the potential to save many lives. This review attempts to describe what is known about CPA toxicity, theories of CPA toxicity, and strategies to reduce CPA toxicity. Critical analysis and suggestions are also included.

PMID:
25826677
PMCID:
PMC4620521
DOI:
10.1089/rej.2014.1656
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center